Search hospitals > Ontario > KINGSTON

Hotel Dieu Hospital

Claim this profile
KINGSTON, Ontario K7L 5G2
Conducts research for Colonoscopy
Conducts research for Anxiety Disorders
Conducts research for Depression
Conducts research for Cataract
Conducts research for Alzheimer's Disease
52 reported clinical trials
0 medical researchers
Photo of Hotel Dieu Hospital in KINGSTONPhoto of Hotel Dieu Hospital in KINGSTONPhoto of Hotel Dieu Hospital in KINGSTON

Summary

Hotel Dieu Hospital is a medical facility located in KINGSTON, Ontario. This center is recognized for care of Colonoscopy, Anxiety Disorders, Depression, Cataract, Alzheimer's Disease and other specialties. Hotel Dieu Hospital is involved with conducting 52 clinical trials across 73 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Hotel Dieu Hospital

Depression
Bipolar Disorder
Mental Health Issue
Post-Traumatic Stress Disorder
Colon Cleansing
Colonoscopy
Depression, Bipolar Disorder
Anxiety
Palliative Care
Cancer
Image of trial facility.

eCBT Plus vs Multi-professional Care Team

for Depression

This trial tests an online therapy called e-CBT for people with depression. It compares the effectiveness of AI versus a healthcare team in deciding the level of care needed. The goal is to find a cost-effective way to reduce depression symptoms and improve treatment adherence. Internet-based cognitive behavioral therapy (ICBT) has been shown to be effective in treating depression in several studies.
Recruiting1 award N/A4 criteria
Image of trial facility.

e-CBT

for Bipolar Disorder

The lifetime prevalence of Bipolar II is 0.4% with the time spent with depressive symptoms outnumbering the time spent with hypomanic symptoms by 35 to 1. Regarding current treatment options, psychotherapy is effective for managing depressive symptoms, with CBT being particularly efficacious. Unfortunately, CBT is often not a feasible treatment option. Electronic CBT (e-CBT) is more accessible for treating various mental illnesses with evidence suggesting it can increase treatment adherence and patient satisfaction. Moreover, e-CBT is suggested to have comparable outcomes to in-person CBT in the treatment of depression and anxiety. Typically, patient-clinician interactions of e-CBT are administered through email however, this is an insecure, unsustainable, and non-scalable treatment delivery method. The proposed study will use the Online Psychotherapy Tool (OPTT), a secure cloud-based platform for the delivery of e-CBT. The aim is to evaluate the feasibility and effectiveness of using OPTT for the treatment of BAD-II with depressive symptoms, while also analyzing social, cultural, and personal factors affecting patients' experience. Participants (n = 80) diagnosed with BAD-II in a depressive episode will be recruited from the Mood and Anxiety Clinic at Providence Care Hospital in Kingston, Ontario, Canada. Eligible participants will then be randomly assigned to either the treatment group (e-CBT plus treatment as usual (TAU)) (n = 40) or the control group (TAU) (n = 40) where they will complete the 12-week program. Participants in the TAU group will be offered the e-CBT program after the first 12 weeks if they wish to take part. Participants in the e-CBT group will complete weekly modules mirroring in-person CBT content and complete homework assignments that will be evaluated by a clinician who will provide personalized feedback through OPTT. Progression/regression of participants will be analyzed using the MADRS, YMRS, and CGI-BP-M questionnaires administered at baseline, after week 6, and after week 12. Personal, social, and cultural factors impacting participant experience will be investigated through an in-depth interview utilizing focus groups. The findings from this study will be the first on the effectiveness of delivering e-CBT to patients with BAD-II with residual depressive symptoms. This approach can provide an innovative method to address the barriers associated with in-person psychotherapy.
Recruiting1 award N/A5 criteria
Image of trial facility.

Online Psychotherapy

for Anxiety and Depression in Cancer Patients

The demand for mental health problems, particularly depression and anxiety, is three times greater in Oncology and Palliative Care Centres than in the general population. There are unique factors in this population that make them more susceptible to mental health challenges. The disease itself, the adjustment to a chronic/fatal diagnosis, and the treatment options can all perpetuate the development of mental illness. Despite the well-established association, there have been barriers to access suitable treatment for these patients. Online Psychotherapy is an effective treatment option that may address many of these barriers. This modality has been proven effective in addressing depression and anxiety in other populations. To date, there has been no psychotherapy module developed specifically for oncology and palliative care patients to our knowledge. The aim is to establish the first academic e-psychotherapy treatment option to address mood and anxiety disorders in oncology and palliative care patients. The investigators will use the Online Psychotherapy Tool (OPTT), a secure cloud-based platform for online delivery of e-CBT, developed by the PI. The proposed study aims to establish the feasibility and effectiveness of delivering online psychotherapy to oncology and palliative care patients who have a comorbid depressive or anxiety disorder. The patients will be enrolled in an 8-week program with a combination of cognitive behavioural therapy (CBT) and Mindfulness techniques delivered via a series of modules. They will receive individualized feedback from a trained therapist weekly. It is hypothesized that delivering this psychotherapeutic intervention in this manner will have great adherence. The aim is to prove that it will improve the quality of life and decrease symptoms of depression and anxiety in this underserved patient population.
Recruiting1 award N/A4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Hotel Dieu Hospital?
Hotel Dieu Hospital is a medical facility located in KINGSTON, Ontario. This center is recognized for care of Colonoscopy, Anxiety Disorders, Depression, Cataract, Alzheimer's Disease and other specialties. Hotel Dieu Hospital is involved with conducting 52 clinical trials across 73 conditions. There are 0 research doctors associated with this hospital, such as .